We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
  • SKIP TO CONTENT
  • SKIP NAVIGATION
  • Drug News
    • Trending
    • Commercial Operations
    • GMPs, Inspections and Audits
    • Postmarket Safety
    • Quality
    • Regulatory Affairs
    • Research and Development
    • Submissions and Approvals
    • FDAnews Drug Daily Bulletin
    • Drug Industry Daily
  • Device News
    • Trending
    • Commercial Operations
    • Inspections and Audits
    • Postmarket Safety
    • Quality
    • Regulatory Affairs
    • Research and Development
    • Submissions and Approvals
    • FDAnews Device Daily Bulletin
    • FDAnews Device Daily Bulletin Premium
  • Books
    • FDAnews Books Library
    • Drug Books
    • Device Books
  • Training/Events
    • Webinar Training Pass
    • Events
  • Resources
    • Form 483s Database
    • FDA Approved Drugs
    • eCFR and Guidances
    • White Papers
  • CenterWatch
  • About Us
    • The Company
    • Contact Us
  • Advertising
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » Store » Devices » EU-MDR: Are You Ready?: Part III – Webinar Recording/Transcript

Other Options

Webinar Recording & Transcript Bundle - April 23, 2020

$287.00

Webinar Recording & Transcript Bundle - April 23, 2020

$258.00

Webinar Recording & Transcript Bundle - April 23, 2020

$244.00

Webinar Recording & Transcript Bundle - April 23, 2020

$230.00

Webinar Recording & Transcript Bundle - April 23, 2020

$215.00
webinar recording

EU-MDR: Are You Ready?: Part III – Webinar Recording/Transcript

$287.00
Devices

Product Details

EU-MDR: Are You Ready? — Part III: Ensuring Your Postmarket Surveillance Readiness

After a successful notified body audit, certificates are issued a CE Mark is applied and the device enters the postmarket surveillance phase. But how well do you understand the PMS phase’s precursors? After all, the notified body document review includes the PMS plan and the plans inside it: the complaint management plan, the trend report plan, and, if applicable, the postmarketing clinical follow-up (PMCF) plan.

Once the PMS phase begins, you must execute your PMS plan: collect data, analyze it and write the evaluation report. If PMCF applies, you must implement the PMCF plan, prepare the PMCF evaluation report and use them to update risk management and, if required, the clinical evaluation report. If you’re unclear about any part — from the premarket plans to the post-market reports — this training is a must.

Join us to understand the EU-MDR PMS system and how to implement the requirements.

Presentation Takeaways:

  • How to prepare your PMS plan
  • How to prepare other related plans — the complaint management plan, the trend report plan and if applicable, the PMCF plan
  • How to determine the reports required for the PMS System
  • How to determine when to prepare a PMCF plan
  • Understand the content of the PMCF Evaluation Report
  • How to link PMS data and PMCF data to risk management

Get a handle on the EU-MDR PMS system so you can successfully implement the requirements.

Meet Your Presenter:

Dan O'Leary is President of Ombu Enterprises, LLC, a company offering training and execution in Operational Excellence, focused on analytic skills and a systems approach to operations management. He has more than 30 years’ experience in quality, operations and program management in regulated industries including medical devices and clinical laboratories. He has a Master’s Degree in Mathematics; is an ASQ-certified Biomedical Auditor, Quality Auditor, Quality Engineer, Reliability Engineer and Six Sigma Black Belt.

Who Will Benefit:

  • Medical device / technology companies
  • Quality manager
  • Regulatory manager
  • Operations manager
  • Design manager
  • Technical manager
  • Clinical manager
  • Authorized representative in Europe
  • Drug Products
    • Quality
    • Regulatory Affairs
    • GMPs
    • Inspections and Audits
    • Postmarket Safety
    • Submissions and Approvals
    • Research and Development
    • Commercial Operations
  • Device Products
    • Quality
    • Regulatory Affairs
    • QSR
    • Inspections and Audits
    • Postmarket Safety
    • Submissions and Approvals
    • Research and Development
    • Commercial Operations
  • Clinical Products
    • Trial Design
    • Data Integrity
    • GCP
    • Inspections and Audits
    • Transparency
  • Privacy Policy
  • Do Not Sell or Share My Data
Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 703.538.7600 – Toll free 888.838.5578

Copyright © 2023. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing